Posted on January 30, 2019 by Sitemaster
The results of a small, randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients already treated on intermittent androgen deprivation therapy (IADT) have recently been published. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adbrogen, curcumin, deprivation, duration, IADT, intermittent, recurrence, tim | 8 Comments »
Posted on May 13, 2009 by Sitemaster
We have just come across a retrospective analysis of a subset of patients originally enrolled in the RTOG 85-31 clinical trial and suggesting that patients who received ≤ 5 years of hormone therapy in association with radiation did worse clinically than those who received > 5 years of adjuvant hormone therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, duration, homone therapy, radiation, RTOG 85-31 | Leave a comment »